 |
|
|
| |
First-in-human pharmacokinetics and pharmacodynamics of oral small-molecule PD-L1 inhibitor AB-101 and correlation to preclinical models
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Emily P Thi1, Sharie C Ganchua1, Christine Espiritu1, Ingrid Graves1, Christina L Iott1, Timothy Eley1, Tilly Varughese1,
Varun Sharma1, Fran Xu1, Amanda Pohl1, Andrew G Cole1, Gavin D Heffernan1, Seyma Ozturk1, Troy O Harasym1,
Angela M Lam1,
Edward Gane2, Michael J Sofia1, Karen D Sims1
1 Arbutus Biopharma Inc., Warminster, PA, USA; 2 University of Auckland and New Zealand Clinical Research,
Auckland, New Zealand
Pdf poster attached
Download the PDF
|
| |
|
|
|
|
|
